• Like
Global Research Digital Breast Tomosynthesis Market and Industry Analysis 2013 – 2019
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

Global Research Digital Breast Tomosynthesis Market and Industry Analysis 2013 – 2019

  • 199 views
Published

Brest cancer is one of the most common cancers among women, with an estimate of about 500,000 mortalities in 2011 according to the World Health Organization (WHO). Although breast cancer is considered …

Brest cancer is one of the most common cancers among women, with an estimate of about 500,000 mortalities in 2011 according to the World Health Organization (WHO). Although breast cancer is considered as a disease of developed countries, its prevalence is rising rapidly in the developing countries owing to urbanization and adoption of sedentary and stressful lifestyle. According to WHO, in 2012 an estimated of 70,000 females in India died due to breast cancer, while in China about 48,000 deaths were recorded and in the U.S. 44,000 deaths were recorded for breast cancer.

Browse Full Report with TOC: http://www.transparencymarketresearch.com/digital-breast-tomosynthesis.html

Follow In LinkedIn: http://www.linkedin.com/today/post/article/20140609073204-263590413-digital-breast-tomosynthesis-market

Published in Health & Medicine , Business
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
No Downloads

Views

Total Views
199
On SlideShare
0
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
1
Comments
0
Likes
2

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. Digital Breast Tomosynthesis Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019 Alina Martin  Flat 10% Discount   Free Customization as per your requirement   You will get Custom Report Syndicated Report Price   Report will be Delivered with 15 to 20 working days. sales@transparencymarketresearch.com USA - Canada Toll Free 866-552-3453 Original Price: $4795
  • 2. Brest cancer is one of the most common cancers among women, with an estimate of about 500,000 mortalities in 2011 according to the World Health Organization (WHO). Although breast cancer is considered as a disease of developed countries, its prevalence is rising rapidly in the developing countries owing to urbanization and adoption of sedentary and stressful lifestyle. According to WHO, in 2012 an estimated of 70,000 females in India died due to breast cancer, while in China about 48,000 deaths were recorded and in the U.S. 44,000 deaths were recorded for breast cancer. The survival rate varies across the globe based on diagnosis time and rate along with the availability and affordability of services, with about 80% in North America and 60% in middle income countries. High prevalence globally has led doctors and scientists to take serious measures for early detection for the cancer so that proper care and treatment can be given to the patient. Browse Full Report with TOC: http://www.transparencymarketresearch.com/digital-breast-tomosynthesis.html Developing technology is adding various innovative devices which have helped in early diagnosis of cancers. Digital breast tomosynthesis also referred to as 3D mammography, is one of the technologies being developed for detection and characterization of breast lesions. The technique involves multiple projection images which allow visualization of thin breast sections which reveals cancers buried within normal tissue, allowing better diagnosis of breast cancer. FDA
  • 3. approval of digital breast tomosynthesis, Selenia Dimensions System by Hologic, Inc. in 2011 has boosted the market. Quick adoption, fewer recalls and simultaneous market penetration supported the market growth. In 2013, GE received CE mark for SenoClaire, and entered the European market. The company also plans for regulatory approval in the U.S. Currently the digital breast tomosynthesis market has been more inclined towards North America and Europe where expensive devices can be afforded by medical institutes. An article published by The Boston Globe in 2012 mentions that by 2012 the device was sold to about 300 institutes in the U.S. According to the U.S. FDA, each year about 40 million mammography procedures are performed in the U.S. alone. These procedures may be replaced with digital breast tomosynthesis as it is a better alternative and delivers better results. As the demand for better breast cancer diagnosis increases, the market will hold grounds in Japan, China, India and Brazil, which are considered to be the most profitable opportunities in the future. High cost of the device is the major restraining force for the market growth in Asia-Pacific and Rest of the World. Majority of the buying of expensive medical devices is supported by funding from investors and government. Hence these intermediaries will decide the fate of digital breast tomosynthesis in the developing economies. Rising incidences of breast cancer will also contribute to the market expansion in the future. Thus entry in this lucrative market is also easier, if the device has been successful in
  • 4. the U.S. market. Increasing trend for medical tourism in these regions will also pressurize medical institutes to upgrade to newer technology to deliver better medical services. Countries in Latin America such as Brazil, Mexico, Venezuela and Colombia are developing rapidly. Regulatory scenario in these regions is also favorable, where most of the countries taking support of U.S. FDA and CE approvals. In Mexico, New Health Accord came into effect in the year 2010 which stated that medical devices approved in the U.S. or Canada will receive quicker approval in the country. Chile also demands no additional regulatory and accepts devices approved in the U.S. Key players in the market include Hologic, Inc., GE Healthcare, Siemens, and Dexela Ltd. (subsidiary of Perkin Elmer). This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include  North America  Asia Pacific  Europe  Rest of the World
  • 5. This report provides comprehensive analysis of  Market growth drivers  Factors limiting market growth  Current market trends  Market structure  Market projections for upcoming years This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. Read More Reports on Medical Devices Markets: http://www.transparencymarketresearch.com/medical-devices-market-reports- 6.html Reasons for Buying this Report  This report provides pin-point analysis for changing competitive dynamics
  • 6.  It provides a forward looking perspective on different factors driving or restraining market growth  It provides a technological growth map over time to understand the industry growth rate  It provides a seven-year forecast assessed on the basis of how the market is predicted to grow  It helps in understanding the key product segments and their future  It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors  It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments  It provides distinctive graphics and exemplified SWOT analysis of major market segments About Us:- Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and
  • 7. analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge. Our data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Enquiry before Buying @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_i d=2422 Latest Upcoming Reports: http://www.transparencymarketresearch.com/upcoming.htm Follow In LinkedIn: http://www.linkedin.com/today/post/article/20140609073204-263590413- digital-breast-tomosynthesis-market
  • 8. Contact Us Sheela AK State Tower, 90 State Street, Suite 700, Albany NY – 12207 United States Tel: +1-518-618-1030 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/ Browse Market Research Blog: http://www.tmrblog.com/ http://researchonglobalmarkets.blogspot.com/